ROCHESTER, MI Corporation (PINKSHEETS: OPRX) announced today that it has retained First Capital Investors, Inc. for investor relations.

OPTIMIZERx's CEO, David Harrell, commented, "I believe that our relationship with First Capital Investors will allow us to effectively communicate our unique story to current and future shareholders. Having recently become a public entity, we sought out a relationship with a firm that has a solid understanding of how to communicate with the investing public, an excellent reputation, and who demonstrates professionalism on a daily basis. We believe that we achieve all of this with First Capital."

All analysts, media, institutional and investor questions should be directed to First Capital Investors at 321-221-2910. Additional investor information, including an investor fact sheet, is available for download at http://www.firstcapitalinvestors.com/factsheets/oprx.pdf.

About OPTIMIZERx Corporation

OPTIMIZERx, www.optimizerx.com, is a web-based consumer health care portal that provides savings, support and information to help patients better afford and optimize their prescribed medicines and therapies. The Company focuses on the design, implementation and execution of rebates, discounts, educational and outreach programs; positioning itself as the pivotal location between pharmaceutical manufacturers, physicians and patients. As private health insurance programs continue to push more drug costs down to the patient level, OPTIMIZERx has positioned itself, both in terms of its business strategy as well as its relationships with Big Pharma, to capture a significant amount of the growth that is occurring in this rapidly expanding industry.

About First Capital Investors, Inc.

First Capital Investors is a full-service Capital Markets Advisory and Investor Relations firm. First Capital Investors focuses primarily on small and micro cap companies seeking professional representation to the investing public.

For additional information on OPTIMIZERx or to receive email alerts, please visit: www.firstcapitalinvestors.com.

Forward-Looking Statements:

In this press release we make "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements describe future expectations, plans, results or strategies and can often be identified by the use of terminology such as "may," "will," "estimate," "intend," "continue," "believe," "expect," "anticipate," "could," "potential," "opportunity," or similar terminology. These statements are based upon management's current expectations, assumptions and estimates and are not guarantees of future results or performance. Actual outcomes may differ materially from those projected in these statements due to a variety of risks and uncertainties and other factors, including, among other things: competition; material adverse changes in economic and industry conditions in our markets; technological change; retention and renewal of existing contracts; availability and adequacy of cash flow to satisfy obligations and indebtedness or future needs; protection of intellectual property; security and integrity of software and systems; laws and government regulation, including those relating to gaming licenses, permits and operations; seasonality; dependence on suppliers and manufacturers; factors associated with foreign operations; dependence on key personnel; failure to perform on contracts; resolution of pending or future litigation; labor matters; and stock price volatility. Additional information regarding risks and uncertainties and other factors that could cause actual results to differ materially from those contemplated in forward-looking statements is included from time to time in our filings with the SEC, including our most recent Annual Report on Form 10-K. Forward-looking statements speak only as of the date they are made, and except for our ongoing obligations under the U.S. federal securities laws, we undertake no obligation to publicly update any forward-looking statements whether as a result of new information, future events or otherwise.

For further information, please contact: Investor Relations: First Capital Investors, Inc. Email Contact (321) 221-2910

OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024 Click Here for more OptimizeRx Charts.
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024 Click Here for more OptimizeRx Charts.